Eisai Co.

From Wikipedia, the free encyclopedia

Eisai head office, Tokyo
Eisai head office, Tokyo

Eisai Co., Ltd. (エーザイ株式会社 Ēzai Kabushiki-gaisha?) (TYO: 4523) is one of the leading global pharmaceutical companies, ranking among the top 25. Headquartered in Tokyo, Japan, it has some 9,000 employees, among them about 1,500 in research. Two of the key molecules Eisai developed are donepezil (Aricept) and rabeprazole (Aciphex).

[edit] External links